| scholarly article | Q13442814 |
| P50 | author | Yong Dai | Q57016528 |
| Minglin Ou | Q88141577 | ||
| P2093 | author name string | Bo Li | |
| Yong Xu | |||
| Wen Xue | |||
| Peng Zhu | |||
| Chunhong Li | |||
| Jiansheng Xie | |||
| Jiejing Chen | |||
| Weiguo Sui | |||
| Lianghong Yin | |||
| Donge Tang | |||
| P2860 | cites work | A human protein-protein interaction network: a resource for annotating the proteome | Q24324450 |
| Fast and accurate short read alignment with Burrows-Wheeler transform | Q24653853 | ||
| STRING: a database of predicted functional associations between proteins | Q24681946 | ||
| The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data | Q27860742 | ||
| Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II | Q28202828 | ||
| Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene | Q28210464 | ||
| Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis | Q28213090 | ||
| Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation | Q28276221 | ||
| Control of bone formation by the serpentine receptor Frizzled-9 | Q28587080 | ||
| Fast and accurate long-read alignment with Burrows-Wheeler transform | Q29547193 | ||
| A framework for variation discovery and genotyping using next-generation DNA sequencing data | Q29547262 | ||
| Evidence for dynamically organized modularity in the yeast protein-protein interaction network | Q29614449 | ||
| Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts | Q30398603 | ||
| Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery | Q35037783 | ||
| Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis | Q35594915 | ||
| Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway | Q36090810 | ||
| Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia | Q37359244 | ||
| Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models | Q37467923 | ||
| Defining pluripotent stem cells through quantitative proteomic analysis. | Q37844151 | ||
| Osteopetrosis: genetics, treatment and new insights into osteoclast function. | Q38123371 | ||
| Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine. | Q38372922 | ||
| TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress | Q38864381 | ||
| Large-Scale Identification of Protein Crotonylation Reveals Its Role in Multiple Cellular Functions. | Q38943902 | ||
| The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible | Q39125771 | ||
| Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient | Q39331956 | ||
| Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis. | Q40543995 | ||
| Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease | Q40873138 | ||
| High-resolution analysis with novel cell-surface markers identifies routes to iPS cells | Q41862220 | ||
| Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells | Q42672671 | ||
| Modeling familial Alzheimer's disease with induced pluripotent stem cells | Q42817521 | ||
| Rapid gene identification in a Chinese osteopetrosis family by whole exome sequencing | Q43484405 | ||
| Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations. | Q43913723 | ||
| Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation | Q43914751 | ||
| Proteome-wide identification of lysine 2-hydroxyisobutyrylation reveals conserved and novel histone modifications in Physcomitrella patens | Q43985902 | ||
| Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations. | Q44621304 | ||
| Generation of systemic lupus erythematosus-specific induced pluripotent stem cells from urine | Q45885275 | ||
| Modeling brain disease in a dish: really? | Q48471179 | ||
| [Modeling familial Alzheimer's disease with induced pluripotent stem cells]. | Q50926550 | ||
| Osteopetrosis | Q56335726 | ||
| Carbonic Anhydrase II Deficiency: A Rare Case of Severe Obstructive Sleep Apnea | Q56360085 | ||
| Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report | Q61851821 | ||
| Osteopetroses, emphasizing potential approaches to treatment | Q64369743 | ||
| A fresh look at iPS cells | Q83608099 | ||
| Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients | Q86217985 | ||
| Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods | Q91965003 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 1 | |
| P304 | page(s) | 251 | |
| P577 | publication date | 2019-08-14 | |
| P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
| P1476 | title | Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells | |
| P478 | volume | 10 |
Search more.